Speciality
Subspeciality
- Urology
- Uro-oncology
Areas of interest
Benign Prostatic Hyperplasia (BPH), Focal therapy for Prostate Cancer
About
Prof Mark Frydenberg specialises in urological cancer management, assessment of haematuria and raised PSA, management of benign prostate disease. Urologic Oncology Fellow Mayo Clinic 1991/2, Chairman, Department of Urology Monash Health 1997-2017, President Urological Society of Australia and New Zealand 2015-2017, Urology Council member, Royal Australasian College of Surgeons 2017 to present, Academic Director of Urology, Cabrini Health 2019 to present, Board member Peninsula Health. Published in excess of 235 peer reviewed articles as of July 2021, was awarded an AM for services to medicine in 2016.
Consulting locations
Consulting Location
Ground Floor
322 Glenferrie Road
Malvern
VIC
3144
Consulting Location
Suite 21
Isabella Street
Malvern
VIC
3144
Epworth locations
Qualifications
- MBBS University of Melbourne
- FRACS (Urology) 1991
- Fellowship - Urologic Oncology, Mayo Clinic, Rochester, Minnesota, USA
Research
- Published > 235 peer reviewed articles as of July 2021
Professional Associations
- Urological Society of Australia and New Zealand
- Society of Urologic Oncology
- American Urological Society
- European Association of Urology
- American Association of Genitourinary Surgeons
- Urological Research Society
Public Appointments
- Board member Peninsula Health
- Bairnsdale Regional Health Service